About Redx Pharma
Redx Pharma is a company based in Liverpool (United Kingdom) founded in 2010 was acquired by Redmile Group in May 2020.. Redx Pharma offers products and services including Zelasudil, RXC008, and Zamaporvint. Redx Pharma operates in a competitive market with competitors including Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
- Headquarter Liverpool, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Redx Pharma Plc
- Date of Incorporation 07 Sep, 2010
- Jurisdiction MACCLESFIELD, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$17.18 M (USD), Post-IPO
Oct 18, 2023
-
Investors
Polar Capital
& 6 more
-
Employee Count
Employee Count
-
Acquired by
Redmile Group
(May 01, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Redx Pharma
Redx Pharma offers a comprehensive portfolio of products and services, including Zelasudil, RXC008, and Zamaporvint. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats interstitial lung diseases and fibrotic indications effectively.
Targets fibrostenotic Crohn’s disease with GI-restricted action.
Focuses on Wnt-ligand driven cancers as targeted therapy.
Unlock access to complete
Unlock access to complete
Funding Insights of Redx Pharma
- Total Funding Total Funding
- Total Rounds 11
- Last Round Post-IPO — $17.2M
-
First Round
First Round
(24 Mar 2016)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Post-IPO - Redx Pharma | Valuation |
investors |
|
| May, 2022 | Amount | Post-IPO - Redx Pharma | Valuation |
investors |
|
| Dec, 2020 | Amount | Post-IPO - Redx Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Redx Pharma
Redx Pharma has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Polar Capital, Sofinnova Partners and Invus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Founded Year | Domain | Location | |
|
Long-term private equity investments in transformational opportunities are pursued.
|
Founded Year | Domain | Location | |
|
Private equity investments are directed across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Redx Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Redx Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Redx Pharma Comparisons
Competitors of Redx Pharma
Redx Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| domain | founded_year | HQ Location |
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Redx Pharma
Frequently Asked Questions about Redx Pharma
When was Redx Pharma founded?
Redx Pharma was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Where is Redx Pharma located?
Redx Pharma is headquartered in Liverpool, United Kingdom.
What does Redx Pharma do?
Redx Pharma was founded in 2010 and is based in Liverpool, United Kingdom. Small molecule therapeutics are developed by the company targeting cancer, infectious diseases, and autoimmune conditions within the pharmaceutical sector. Operations center on drug discovery and early-stage development, with a focus on innovative treatments. The companys online presence is maintained at redxpharma.com, supporting investor and stakeholder engagement.
Who are the top competitors of Redx Pharma?
Redx Pharma's top competitors include Merck, Roivant Sciences and Amgen.
What products or services does Redx Pharma offer?
Redx Pharma offers Zelasudil, RXC008, and Zamaporvint.
Who are Redx Pharma's investors?
Redx Pharma has 7 investors. Key investors include Polar Capital, Sofinnova Partners, Invus, Redmile Group, and Polar Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.